Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.035x

Based on the latest financial reports, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$112.62 Million ≈ $3.55 Million USD) by net assets (NT$3.21 Billion ≈ $101.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Chunghwa Chemical Synthesis & Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Chunghwa Chemical Synthesis & Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Chunghwa Chemical Synthesis & Biotech Co balance sheet liabilities for a breakdown of total debt and financial obligations.

Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chunghwa Chemical Synthesis & Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Crown Seal Public Company Limited BK:CSC	0.028x
Ihlas Holding AS IS:IHLAS	-0.030x
Foodnamoo. Inc KQ:290720	0.008x
Astra Exploration Inc V:ASTR	-0.746x
Apex Science & Engineering Corp TW:3052	0.515x
Great Boulder Resources Ltd AU:GBR	-0.022x
Epitomee Medical Ltd TA:EPIT	-0.416x
Daekyo KO:019680	0.035x

Annual Cash Flow Conversion Efficiency for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 1762 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$3.36 Billion ≈ $105.76 Million	NT$467.65 Million ≈ $14.73 Million	0.139x	+702.20%
2023-12-31	NT$3.35 Billion ≈ $105.55 Million	NT$-77.50 Million ≈ $-2.44 Million	-0.023x	-110.07%
2022-12-31	NT$3.19 Billion ≈ $100.60 Million	NT$733.78 Million ≈ $23.12 Million	0.230x	+203.46%
2021-12-31	NT$2.89 Billion ≈ $91.19 Million	NT$219.18 Million ≈ $6.91 Million	0.076x	+36.88%
2020-12-31	NT$2.50 Billion ≈ $78.72 Million	NT$138.24 Million ≈ $4.36 Million	0.055x	-58.42%
2019-12-31	NT$2.02 Billion ≈ $63.49 Million	NT$268.13 Million ≈ $8.45 Million	0.133x	+12.49%
2018-12-31	NT$1.98 Billion ≈ $62.50 Million	NT$234.66 Million ≈ $7.39 Million	0.118x	+35.20%
2017-12-31	NT$1.82 Billion ≈ $57.38 Million	NT$159.34 Million ≈ $5.02 Million	0.087x	-40.70%
2016-12-31	NT$1.77 Billion ≈ $55.80 Million	NT$261.31 Million ≈ $8.23 Million	0.148x	+245.00%
2015-12-31	NT$1.86 Billion ≈ $58.72 Million	NT$79.70 Million ≈ $2.51 Million	0.043x	+199.40%
2014-12-31	NT$1.62 Billion ≈ $50.91 Million	NT$23.08 Million ≈ $727.18K	0.014x	-83.17%
2013-12-31	NT$1.71 Billion ≈ $53.91 Million	NT$145.24 Million ≈ $4.58 Million	0.085x	-47.02%
2012-12-31	NT$1.68 Billion ≈ $52.79 Million	NT$268.46 Million ≈ $8.46 Million	0.160x	+85.46%
2011-12-31	NT$1.68 Billion ≈ $52.82 Million	NT$144.84 Million ≈ $4.56 Million	0.086x	-47.25%
2010-12-31	NT$1.68 Billion ≈ $53.01 Million	NT$275.61 Million ≈ $8.68 Million	0.164x	-57.67%
2009-12-31	NT$1.19 Billion ≈ $37.63 Million	NT$462.07 Million ≈ $14.56 Million	0.387x	+329.84%
2008-12-31	NT$837.53 Million ≈ $26.39 Million	NT$75.39 Million ≈ $2.38 Million	0.090x	--

About Chunghwa Chemical Synthesis & Biotech Co Ltd

TW:1762 Taiwan Biotechnology

Market Cap

$68.46 Million

NT$2.17 Billion TWD

Market Cap Rank

#20656 Global

#1241 in Taiwan

Share Price

NT$28.25

Change (1 day)

-0.18%

52-Week Range

NT$24.30 - NT$30.00

All Time High

NT$102.50